Comparison of the effects of edoxaban, an oral factor Xa inhibitor, and other anticoagulants on thrombin generation

被引：0
|
作者：
Mendell, J. [1 ]
Li, Y. [1 ]
Samama, M. M. [2 ]
Halim, A-B [1 ]
Song, S. [1 ]
Depasse, F. [3 ]
Kunitada, S. [4 ]
机构：
[1] Daiichi Sankyo Pharma Dev, Edison, NJ USA
[2] Hosp Hotel Dieu, Paris, France
[3] Biomnis Lab, Ivry, France
[4] Daiichi Sankyo Co Ltd, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-176
引用
收藏
页码：575 / 575
页数：1
相关论文
共 50 条
  • [21] Prevention of Stent Thrombosis in Rats by a Direct Oral Factor Xa Inhibitor Edoxaban
    Morishima, Yoshiyuki
    Honda, Yuko
    Kamisato, Chikako
    PHARMACOLOGY, 2019, 103 (1-2) : 17 - 22
  • [22] EFFECT OF NAPROXEN ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF EDOXABAN, AN ORAL FACTOR Xa INHIBITOR.
    Mendell-Harary, J.
    Chen, S.
    Noveck, R. J.
    Lee, F.
    Petrushun, V.
    Shi, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S63 - S63
  • [23] Comparison of the effect of edoxaban, a direct factor Xa inhibitor, with a direct thrombin inhibitor, melagatran, and heparin on intracerebral hemorrhage induced by collagenase in rats
    Shirasaki, Yasufumi
    Morishima, Yoshiyuki
    Shibano, Toshiro
    THROMBOSIS RESEARCH, 2014, 133 (04) : 622 - 628
  • [24] THE EFFECT OF DIRECT ORAL ANTICOAGULANTS ON PLATELET AGGREGATION INDUCED BY FACTOR XA AND THROMBIN
    Papadaki, S.
    Tselepis, A. D.
    ATHEROSCLEROSIS, 2020, 315 : E84 - E84
  • [25] MODULATION OF THROMBIN AND FACTOR-XA GENERATION BY RECOMBINANT HIRUDIN AND OTHER ANTICOAGULANTS IN EXTRINSIC AND INTRINSIC ACTIVATED SYSTEMS
    KAISER, B
    HOPPENSTEADT, JFD
    BIRDSONG, B
    WALENGA, JM
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1311 - 1311
  • [26] Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
    Hillarp, Andreas
    Strandberg, Karin
    Baghaei, Fariba
    Blixter, Inger Fagerberg
    Gustafsson, Kerstin M.
    Lindahl, Tomas L.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (7-8): : 575 - 583
  • [27] Effects of BAY 59-7939, an oral, direct factor Xa inhibitor, on thrombin generation in healthy volunteers.
    Harder, S
    Graff, J
    Hentig, NV
    Misselwitz, F
    Kubitza, D
    Zuelsdorf, M
    Wensing, G
    Mueck, W
    Becka, M
    Breddin, HK
    BLOOD, 2003, 102 (11) : 811A - 811A
  • [28] Enhancement of fibrinolysis by a factor XA inhibitor edoxaban and combination with an inhibitor of activated thrombin-activatable fibrinolysis inhibitor in vitro
    Morishima, Y.
    Kamisato, C.
    Furugohri, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 390 - 390
  • [29] Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban
    Apostolakis, Stavros
    Lip, Gregory Y. H.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (07) : 1057 - 1064
  • [30] Research and development strategy of antithrombotic agents: pharmacology of the oral factor Xa inhibitor edoxaban
    Morishima, Yoshiyuki
    Shibano, Toshiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 30P - 30P
12345